BAYER AG SPON ADR REP 1 NPV (BAYRY)

100.04
1.14 1.15
OTC
Prev Close 98.90
Open 98.94
Day Low/High 98.94 / 100.14
52 Wk Low/High 91.53 / 128.90
Volume 429.22K
Exchange OTC
Shares Outstanding 826.95B
Market Cap 83.95B
Div & Yield N.A. (N.A)

Latest News

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European stocks are in the red Wednesday as government bond yields edge higher amid the global inflation trade.

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Pfizer, Bayer, Shire are among rivals bracing for Roche's ACE910.

Will Seed and Farm-Chemical Producers Sow Our Food Needs in Asia?

Will Seed and Farm-Chemical Producers Sow Our Food Needs in Asia?

A WWF report shows how fragile our hold on the world's ecology is. Does Asia represent the future of food production?

It's Not Too Late to Buy Time Warner, Monsanto, Other M&A Targets

It's Not Too Late to Buy Time Warner, Monsanto, Other M&A Targets

Some of the biggest deals already announced on Wall Street are currently pricing in hefty premiums for investors willing to take the risk.

Four Stock Picks for 2017

Four Stock Picks for 2017

Don't sell these shares just yet.

Bayer Beats Estimates as Drugs Gain While Crops Stall

Bayer Beats Estimates as Drugs Gain While Crops Stall

Strong drug sales allow the German group to increase its full-year earnings forecast, while wilting crop science revenue pose more questions about the wisdom of buying Monsanto.

European Stocks Slide As Oil Falls Back and Earnings Disappoint

European Stocks Slide As Oil Falls Back and Earnings Disappoint

U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.

Cramer: Regulators Are Looking to Kill, Not Bless Mega Mergers

Cramer: Regulators Are Looking to Kill, Not Bless Mega Mergers

This is new doctrine having to do with innovation and the stifling of innovation to create new products.

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

The Swiss fertilizers maker says regulators in the EU and elsewhere have demanded more information.

Don't Succumb to the Buzz of the Mega Merger

Don't Succumb to the Buzz of the Mega Merger

Results have shown that many major "blockbuster" deals aren't blockbuster investments later.

Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Regulatory issues will weigh on this deal, because of populist politics.

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.

Four Stocks That Could Power Your Portfolio in 2017

Four Stocks That Could Power Your Portfolio in 2017

Here is why CBS, Constellation Brands, Monsanto and Aetna will be winners in 2017.

Why Larry Fink May Be the Trustbusters' Next Target

Why Larry Fink May Be the Trustbusters' Next Target

Experts say mutual funds' stakes across an industry can thwart competition and that anti-trust regulators should require them to pare their holdings in that case.

Profit From the M&A Wave With ETFs, Mutual Funds

Profit From the M&A Wave With ETFs, Mutual Funds

Buy mutual funds and exchange-traded funds that buy shares of those companies involved in takeovers.

Oil, Yellen and World GDP Growth: How to Trade the Week Ahead

Oil, Yellen and World GDP Growth: How to Trade the Week Ahead

Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.

Bayer Raises Drug Sales Targets and Leaves Monsanto Combination Trailing

Bayer Raises Drug Sales Targets and Leaves Monsanto Combination Trailing

CEO Werner Baumann increases sales and margin forecasts for pharmaceuticals and insists Monsanto deal will deliver growth and improved profit.

Bayer, Monsanto Brace for Long Climb With Regulators

Bayer, Monsanto Brace for Long Climb With Regulators

Despite intense opposition from farm groups and skepticism from government enforcers, the merging crop technology giants say they expect to win approval by end of 2017.

Crude Selloff Pulls Stocks Lower but Apple Saves Nasdaq

Crude Selloff Pulls Stocks Lower but Apple Saves Nasdaq

Another selloff on commodity markets on Wednesday contributed to stock losses throughout the day.

Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq

Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq

Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.

European Stock Markets Mixed Amid Weakness in Luxury Goods

European Stock Markets Mixed Amid Weakness in Luxury Goods

German Dax leads the board with 0.4% gain.

Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates

Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates

Stocks add to slight gains on Wednesday as Wall Street stabilizes after three days of extreme swings.

U.S. Stocks Rise Despite Oil Declines; Ford Unveils Growth Plan

U.S. Stocks Rise Despite Oil Declines; Ford Unveils Growth Plan

U.S. stocks gained steam on Wednesday, even though oil prices continued to slide.

Stock Futures Edge Higher After a Rocky Three Days

Stock Futures Edge Higher After a Rocky Three Days

Stock futures edge higher on Wednesday as Wall Street appears to stabilize after three days of extreme swings.

Bayer and Monsanto Confirm $66 Billion Deal

Bayer and Monsanto Confirm $66 Billion Deal

The agreement values the world's biggest seed maker at $128 per share and comes with a promise of $1.5 billion of annual synergies.

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures point to a slight rebound for Wall Street on Wednesday; report says Bayer to announce acquisition of Monsanto; Wells Fargo CEO John Stumpf says he won't resign.